| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.29B | 69.54B | 59.51B | 53.35B | 46.19B | 43.42B |
| Gross Profit | 17.63B | 17.87B | 16.02B | 14.16B | 12.68B | 11.84B |
| EBITDA | 8.23B | 11.19B | 9.92B | 8.34B | 7.12B | 6.26B |
| Net Income | 7.10B | 7.45B | 6.52B | 5.42B | 4.52B | 3.96B |
Balance Sheet | ||||||
| Total Assets | 84.83B | 86.49B | 75.05B | 65.50B | 58.83B | 52.59B |
| Cash, Cash Equivalents and Short-Term Investments | 19.47B | 37.90B | 34.86B | 28.09B | 26.21B | 22.65B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 23.49B | 26.82B | 22.61B | 21.56B | 18.97B | 16.06B |
| Stockholders Equity | 58.90B | 57.19B | 50.12B | 41.82B | 37.81B | 34.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.76B | 9.57B | 3.02B | 5.91B | 2.55B |
| Operating Cash Flow | 0.00 | 6.46B | 9.68B | 3.37B | 5.96B | 2.59B |
| Investing Cash Flow | 0.00 | -176.87M | -935.21M | -1.95B | -538.67M | -258.63M |
| Financing Cash Flow | 0.00 | -2.26B | -1.87B | -1.85B | -1.37B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥103.71B | 2.19 | ― | 2.13% | 7.64% | 13.90% | |
75 Outperform | ¥150.64B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
68 Neutral | ¥28.60B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
68 Neutral | ¥28.79B | -28.94 | ― | 2.51% | 8.88% | 2.72% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥104.11B | 15.20 | 2.57% | 1.97% | 19.61% | ― | |
42 Neutral | ¥7.11B | -28.24 | ― | ― | -29.41% | 79.74% |